Metformin in Pregnancy for Women with Type 2 Diabetes: a Review

AbstractPurpose of ReviewTo review the current evidence for the use of metformin in pregnancy for women with type 2 diabetes.Recent FindingsA large, multicenter, double-blind randomized controlled trial found that women with type 2 diabetes in pregnancy treated with metformin as an adjunct to insulin therapy had less gestational weight gain, insulin requirements, caesarian sections, macrosomia, and neonatal adiposity, but more neonates were small for gestational age (SGA) compared with insulin alone. It is unclear if the higher number of SGA infants are a direct result of metformin exposure or mediated through other effects such as less gestational weight gain and improved glycemic control. Additional follow-up studies of offspring exposed to metformin in utero are required.SummaryMetformin may be a useful adjunctive treatment for women with type 2 diabetes in pregnancy to help meet glycemic targets if there are no concerns for or indications of SGA.
Source: Current Diabetes Reports - Category: Endocrinology Source Type: research